News/announcements

 

Annual General Meeting Feedback May 2009

Bioquell PLC discloses that all the Resolutions set out in the Notice of AGM were passed at the Annual General Meeting (“AGM”) held earlier today.

Read more

Interim Management Statement May 2009

Bioquell PLC announces its Interim Management Statement for the period from 1 January, 2009 to 18 May, 2009.
 

Read more

Directors’ exercise of options and acquisition of shares April 2009

Nick Adams, Chief Executive of Bioquell PLC informed the Company that he had exercised 80,000 options over Shares. Mark Bodeker, Chief Operating Officer, informed the Company that he had exercised 80,000 options over Shares.

Read more

Notice of Annual General Meeting May 2009

The Annual General Meeting of Bioquell PLC will take place on Thursday 28 May at the Company’s offices, 52 Royce Close, West Portway, Andover, Hampshire, SP10 3TS.

Read more

Grant of options to Directors March 2009

Bioquell PLC announces that Nicholas Adams, Chief Executive, and Mark Bodeker, Chief Operating Officer and Finance Director, have been awarded options (“Options”), with vesting preconditions, over ordinary Bioquell shares.

Read more

Annual report and accounts 2008

The Bioquell annual report 2008 has now been published.

Read more

BIOQUELL delivers strong growth in pre-tax profit and cash in 2008

Bioquell PLC announces its results for the year ended 31 December, 2008.
 

Read more

Bioquell takes top prize at the Department of Health HCAI technology innovation summit

Bioquell has won a prestigious award from the Department of Health and NHS Purchasing and Supply Agency (PASA) in recognition of its Hydrogen Peroxide Vapour (HPV) decontamination technology, offering the greatest contribution in controlling Clostridium difficile.

Read more

Interim results 2008

Bioquell PLC announces its interim results for the six months ended 30 June 2008. 

Read more

Purchase of ordinary shares, July 2008

Mr Andrew Muir pursuant to DTR 5.1.2(1) on 15 July 2008 purchased BIOQUELL PLC ordinary shares and his total holding now comprises 2,150,257 Shares representing approximately 5.2% of the issued Share capital.

Read more